Filing Details

Accession Number:
0001209191-23-037106
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-14 17:14:46
Reporting Period:
2023-06-12
Accepted Time:
2023-06-14 17:14:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070494 Acadia Pharmaceuticals Inc ACAD Pharmaceutical Preparations (2834) 061376651
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365619 Laura Brege C/O Acadia Pharmaceuticals Inc.
12830 El Camino Real, Suite 400
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-12 4,500 $24.87 13,502 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.68 through $25.02, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.